IP Library Granted Patent US 9,133,248
Granted Patent B2
US 9,133,248 · App. 13/508,659 · Granted Sep 15, 2015

Methods of propagating monkey adenoviral vectors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,133,248
App. No.
13/508,659
Granted
Sep 15, 2015
Kind
B2
Abstract

The invention provides methods for propagating a monkey adenovirus in a cell including a human cell, comprising one or more gene products isolated from a human adenovirus. Also provided are methods for propagating wherein the monkey adenovirus comprises a nucleic acid sequence encoding a human adenovirus gene product. The invention further provides a monkey adenovirus. including a replication-deficient monkey adenovirus, obtained by such propagation methods.

Claims (9)

1. A method of propagating a monkey adenovirus, which method comprises contacting a cell with the monkey adenovirus, wherein the cell expresses a gene product encoded by one or both of the E1A region and the E1B region, and a gene product encoded by a portion of the E4 region consisting essentially of E4 ORF6, of a human adenovirus, whereby the monkey adenovirus is propagated in the cell, wherein monkey refers to both new world and old world monkeys, and does not include any member of the family Hominidae.

2. The method of claim 1 , wherein the human adenovirus is a species C human adenovirus.

3. The method of claim 2 , wherein the portion of the E4 region is E4 ORF6.

4. The method of claim 3 , wherein the cell is a human cell.

5. The method of claim 4 , wherein the cell is a HEK-293 cell or a PerC.6 cell.

6. The method of any one of claims 1 - 5 , wherein the monkey adenovirus is replication-deficient.

7. The method of claim 6 , wherein the monkey adenovirus requires complementation of one or more of the E1A region, the E1B region, and the E4 region of the adenoviral genome for propagation.

8. The method of claim 7 , wherein the monkey adenovirus comprises a deficiency in the E1 region and a deficiency in at least a portion of the E4 region of the adenoviral genome.

9. The method of claim 8 , wherein the monkey adenovirus further comprises a deficiency in the E3 region of the adenoviral genome.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Sep 3, 2025
From: PRECIGEN, INC.; GENVEC LLC; PRECIGEN ACTOBIO, INC.; EXEMPLAR GENETICS, LLC
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 072828/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2012
From: GALL, JASON G.D.; BROUGH, DOUGLAS E.; MCVEY, DUNCAN L.; KAHL, CHRISTOPH
To: GENVEC, INC.
Reel/Frame 028175/0457 →